Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding
The Pharma Data
AUGUST 20, 2020
Several pharma giants—including Merck, Novartis, Eli Lilly and Pfizer—have just lost procurement deals in China under the country’s new bidding system. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. DEVELOP A UNIFIED SCIENTIFIC VOICE.
52 
Let's personalize your content